60 Degrees Pharmaceuticals (SXTP) Regains Nasdaq Compliance

60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) announced today that on August 26, 2024 it received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.

The Company had been notified by Nasdaq on February 27, 2024 that it was not in compliance with the Minimum Bid Price Requirement because its common stock had failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. In order to regain compliance with the Minimum Bid Price Requirement, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days, which was achieved during the period between August 12, 2024 and August 23, 2024. The Company’s closing price was $1.81 on August 23, 2024.

You May Also Be Interested In

• Quest Diagnostics to add Roche pTau217 Alzheimer's blood test in Q4
• Innovative Eyewear to place Lucyd Armor in 150+ big box stores
• FDA places clinical hold on Regenxbio's RGX-121 gene therapy for Hunter Syndrome